Conmed (CNMD) Stock Statistics & Valuation Metrics
Total Valuation
Conmed has a market cap or net worth of MXN 24.80B. The enterprise value is MXN 2.16B.
- Market Cap
- MXN 24.80B
- Enterprise Value
- MXN 2.16B
Share Statistics
Conmed has 29,803,324 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 29,803,324
- Owned by Insiders
- 0.19%
- Owned by Institutions
- 3.44%
Financial Efficiency
Conmed’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.64%.
- Return on Equity (ROE)
- 0.05
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 4.64%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 352.43K
- Profits Per Employee
- 12.07K
- Employee Count
- 3,900
- Asset Turnover
- 0.59
- Inventory Turnover
- 1.83
Valuation Ratios
The current PE Ratio of Conmed is 18.30. Conmed’s PEG ratio is 1.05.
- PE Ratio
- 18.30
- PS Ratio
- 0.96
- PB Ratio
- 1.25
- Price to FCF
- 9.95
- Price to Operating Cash Flow
- 9.06
- PEG Ratio
- 1.05
Income Statement
In the last 12 months, Conmed had revenue of 1.37B and earned 47.05M in profits. Earnings per share was 1.52.
- Revenue
- 1.37B
- Gross Profit
- 725.38M
- Operating Income
- 141.13M
- Pretax Income
- 71.12M
- Net Income
- 47.05M
- EBITDA
- 176.49M
- Earnings Per Share (EPS)
- 1.52
Cash Flow
In the last 12 months, operating cash flow was 146.31M and capital expenditures -13.62M, giving a free cash flow of 132.69M billion.
- Operating Cash Flow
- 146.31M
- Free Cash Flow
- 132.69M
- Free Cash Flow per Share
- 4.43
Dividends & Yields
Conmed pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 10.05%
- Earnings Yield
- 5.54%
Stock Price Statistics
- Beta
- -0.06
- 52-Week Price Change
- -23.88%
- 50-Day Moving Average
- 759.89
- 200-Day Moving Average
- 729.97
- Relative Strength Index (RSI)
- 86.93
- Average Volume (3m)
- ―
Important Dates
Conmed upcoming earnings date is Feb 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Conmed as a current ratio of 2.14, with Debt / Equity ratio of 80.82%
- Current Ratio
- 2.14
- Quick Ratio
- 1.01
- Debt to Market Cap
- 0.66
- Net Debt to EBITDA
- 4.50
- Interest Coverage Ratio
- 4.54
Taxes
In the past 12 months, Conmed has paid 24.06M in taxes.
- Income Tax
- 24.06M
- Effective Tax Rate
- 0.34
Enterprise Valuation
Conmed EV to EBITDA ratio is 9.88, with an EV/FCF ratio of 15.73.
- EV to Sales
- 1.52
- EV to EBITDA
- 9.88
- EV to Free Cash Flow
- 15.73
- EV to Operating Cash Flow
- 14.27
Balance Sheet
Conmed has MXN 47.97M in cash and marketable securities with MXN 815.87M in debt, giving a net cash position of -MXN 767.89M billion.
- Cash & Marketable Securities
- MXN 47.97M
- Total Debt
- MXN 815.87M
- Net Cash
- -MXN 767.89M
- Net Cash Per Share
- -MXN 25.77
- Tangible Book Value Per Share
- -MXN 9.81
Margins
Gross margin is 57.20%, with operating margin of 12.11%, and net profit margin of 5.36%.
- Gross Margin
- 57.20%
- Operating Margin
- 12.11%
- Pretax Margin
- 7.66%
- Net Profit Margin
- 5.36%
- EBITDA Margin
- 15.43%
- EBIT Margin
- 10.11%
Analyst Forecast
The average price target for Conmed is MXN 892.18, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- MXN 892.18
- Price Target Upside
- 3.26% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 5
- Revenue Growth Forecast
- -8.48%
- EPS Growth Forecast
- 3.53%
Scores
- Smart Score
- 8
- AI Score
- ―